Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Watchlist
Price: 331.2 SEK 1.85% Market Closed
Market Cap: 114B SEK
Have any thoughts about
Swedish Orphan Biovitrum AB (publ)?
Write Note

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Swedish Orphan Biovitrum AB (publ)
Cash & Cash Equivalents Peer Comparison

Comparables:
BIOG B
BONEX
B
BINV
VITR
BIOA B

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Cash & Cash Equivalents
kr594m
CAGR 3-Years
41%
CAGR 5-Years
-11%
CAGR 10-Years
0%
Biogaia AB
STO:BIOG B
Cash & Cash Equivalents
kr1.5B
CAGR 3-Years
2%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Cash & Cash Equivalents
kr153.2m
CAGR 3-Years
-12%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
BioInvent International AB
STO:BINV
Cash & Cash Equivalents
kr717.4m
CAGR 3-Years
-17%
CAGR 5-Years
31%
CAGR 10-Years
26%
Vitrolife AB
STO:VITR
Cash & Cash Equivalents
kr925m
CAGR 3-Years
-42%
CAGR 5-Years
9%
CAGR 10-Years
23%
BioArctic AB
STO:BIOA B
Cash & Cash Equivalents
kr611.6m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
N/A

See Also

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents?
Cash & Cash Equivalents
594m SEK

Based on the financial report for Sep 30, 2024, Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents amounts to 594m SEK.

What is Swedish Orphan Biovitrum AB (publ)'s Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
0%

Over the last year, the Cash & Cash Equivalents growth was -12%. The average annual Cash & Cash Equivalents growth rates for Swedish Orphan Biovitrum AB (publ) have been 41% over the past three years , -11% over the past five years .

Back to Top